|Last Price$33.46||Day Change (%)0.15%|
|Open Price$33.22||Day Change ($)0.05|
|Day Range33.21–33.61||52-Week Range19.42–33.77|
As of Thu 5/28/2015 5:32:00 PM | USD
PharMerica Is Unable to Present at the UBS 2015 Global HealthCare Conference Due to Weather-Related Travel Delays
Memblaze Launches New PBlaze4 Series of NVMe Compliant PCIe SSDs
Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's Contracture
Investment Advisor magazine’s Editor-in Chief John Sullivan talks with Envestnet | PMC Investment Analyst Chris Devaney about the research behind the selection of the nominees and winners in the Mid-Cap Equity category.
The assumptions, opinions and estimates in this report constitute our judgment as of the date of this material and are subject to change without notice. The comments should not be construed as a recommendation of individual holdings or market sectors, but as an illustration of the management ...
CA new software vision provides strategic focus, but growth remains elusive.
Goldman Sachs funds' group suffers another departure and more.
Plus, BlackRock and Fidelity target-date fund news, and more.
Week ending July 21